BD (Becton, Dickinson and Company) announced the CE Mark application for its Liverty™ TIPS Stent Graft, aiming to enhance portal hypertension care across the European Union. This next-generation innovation represents a significant step in medical device technology.
BD Launches New TIPS Stent Graft in European Union
medical-deviceshealthcare-innovationEU-marketBDX


